KBRA Upgrades and Affirms Ratings for BHG Securitization Trusts
4 Sep 2025 | New York
KBRA upgrades its ratings on 16 classes of notes and affirms ratings on 12 classes of notes issued from nine BHG Securitization Trust transactions. KBRA’s analysis indicated that existing credit enhancement for the notes is sufficient to support the revised and affirmed ratings. All of the securities with upgraded ratings experienced increased credit enhancement. The data used for this review is as of the August 2025 distribution date (July 2025 collection period). To date, the securities have received timely interest payments.
In performing its rating review, KBRA utilized its General Global Rating Methodology for Asset Backed Securities and Consumer Loan ABS Global Rating Methodology, as well as its Global Structured Finance Counterparty Methodology and ESG Global Rating Methodology. In determining these rating actions, KBRA reviewed the collateral performance to date and projected the remaining loss for the transactions based on current assumptions. The rating actions, along with related deal and tranche performance information, are available in spreadsheet form in the accompanying Bankers Healthcare Group Comprehensive Surveillance Dashboard. BHG 2025-1CON and BHG 2025-2CON were not included in this review as they are less than six months seasoned.
The loans supporting the transactions were originated by Bankers Healthcare Group, LLC (“BHG” or the “Company”). BHG was founded in 2001 and provides small business loans (“Commercial Loans”) and unsecured consumer loans (“Consumer Loans”) primarily to prime, high-income professionals. BHG began offering Commercial Loans in 2001 and introduced a consumer lending product in 2014. The Company initially provided business loans to licensed medical professionals only, expanded to offer personal loans to its customer base and has more recently expanded its offerings to include additional high income and high credit quality professionals such as attorneys, financial advisors, and accountants. With corporate headquarters in Davie, Florida, and financial headquarters in Syracuse, New York, BHG has provided more than $24 billion in funding to over 220,000 borrowers since inception. Pinnacle Bank, a Tennessee state-chartered bank and subsidiary of Pinnacle Financial Partners, Inc. (“PNFP”), owns 49% of the Company. On July 25, 2025, PNFP announced a merger with Synovus Financial, which is anticipated to be completed in Q1 2026.
BHG has been profitable since inception, reporting net income of approximately $135 million for the FY ended 2024 and $44 million for the three months ending March 31, 2025. Cash and cash equivalents and stockholder’s equity were approximately $763 million and $525 million, respectively, as of March 31, 2025.
As of June 30, 2025, the Company has drawn $750 million of its $2 billion in funding capacity from five separate warehouse facilities, one revolving corporate facility, and two term loans. The Company also has $226 million in outstanding joint venture agreements with various regional banks who fund 100% of principal of new originations and share the interest and credit risk with BHG. It also has one outstanding loan sale agreement that has an outstanding agreement of $143 million. The Company has issued 11 144a term ABS securitizations totaling $3.6 billion.
Click here to view the report.
For additional information regarding a specific transaction, see the list below to access ratings, reports, and disclosures:
- BHG Securitization Trust 2021-A
- BHG Securitization Trust 2021-B
- BHG Securitization Trust 2022-A
- BHG Securitization Trust 2022-B
- BHG Securitization Trust 2022-C
- BHG Securitization Trust 2023-A
- BHG Securitization Trust 2023-B
- BHG Securitization Trust 2024-1CON
- Bankers Healthcare Group Securitization Trust 2020-A (BHG 2020-A)